AbbVie's €150m investment in its new facility will enable “cutting-edge” research to be conducted at its Ludwigshafen site long term. #researchanddevelopment #pharma #EPRTalks

Under a new initiative, manufacturers could increase productivity via innovative tech, enabling faster patient access to new medicines. #digitalisation #pharmaceuticalmanufacturing #EPRTalks

✨ Introducing our latest whitepaper: 'Manufacturing with Bruker’s Fourier PAT.'

Discover how data-driven, real-time control with on-line NMR analysis maximises efficiency and benefits.

Download now: bit.ly/4donR6y

#manufacturing #bruker #fourierPAT #innovation

⭐ Just published! ⭐

Are you looking for the latest insights into bioprocessing/bioproduction?

Our new In-Depth Focus features articles on bioreactor size, as well as bioprocess development and manufacturing of bioconjugated products.

Download now >> bit.ly/3JFWxTx

In its April meeting, the CHMP recommended approval of eight new medicines, including treatments for cancer and autoimmune diseases. #regulatory #pharmaceuticals #EPRTalks

An innovative study investigating spectroscopic analysis could lead to accelerated data acquisition in ultrafast #spectroscopy . #analyticaltechniques #EPRTalks

🔍 Challenges in microorganism testing? We've got you covered!

Discover more in our upcoming webinar with Rapid Micro Biosystems by registering with this link: bit.ly/4cBYXj8

#rapid #sterility #microorganism

Pfizer has attained its first approval for a gene therapy from the US FDA, indicated to treat the rare blood disorder haemophilia B. #cellandgenetherapy #raredisease #EPRTalks

The method for whole-genome analysis of fungal species is “highly suitable” for QC monitoring of medicinal materials, the paper suggests. #microbiology #qualitycontrol #EPRTalks

Our first Issue of 2024 is available to download! It includes articles on 𝐬𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧 & 𝐩𝐮𝐫𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 and 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐚𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚𝐥 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲.

👉 Download now: bit.ly/3Whyx0y

#pharma #processanalytical #EPR2024

The new members of the Cell and Gene Therapy Catapult’s board hold expertise across therapy development, digitalisation and leadership. #drugdevelopment #cellandgenetherapy #EPRTalks

Research has shown the suitability of #3Dprinting for preparing tailored and effective treatments for rare diseases in a hospital setting. #formulation #EPRTalks

EC approval follows a development and commercialisation agreement made in September 2023 between Sandoz and Samsung Bioepis for ustekinumab. #regulatory #biosimilars #EPRTalks

Certain atopic dermatitis patients can strive for both little to no itch and clearer skin with upadacitinib, topline study results suggest. AbbVie #drugdevelopment #EPRTalks

The driving factor for protein particle formation is surface mediated in protein only formulations in manufacturing, research asserts. #biologics #pharmamanufacturing #EPRTalks

Despite some challenges, for the #Alzheimers #drugdevelopment pipeline, 2024 is a “learning year”, an expert on the disease says. #EPRTalks

Maximise the effectiveness and have the benefits of data-driven, NMR analysis coupled with process analytical technology.

📈 Download the ideal whitepaper: 'Manufacturing with Bruker's Fourier PAT,' using this link bit.ly/4donR6y

#PAT #nuclear #analysis

Greater demand for prefilled insulin syringes is driving growth for the #pharmaceutical parenteral #packaging market, a report states. #EPRTalks

⚡ We're here with MasterControl to share pharma quality and manufacturing trends ⚡

Discover more about:

✅ Growth opportunities
✅ Leveraging real-world data
✅ Adopting configurable LC/NC solutions

Download now: bit.ly/3P9eGwm

#Pharma #Tech #Trends #AI

At the 2024 Advanced Therapies congress, panellists discussed the lack of women leaders in the CGT field, including the potential causes. #cellandgenetherapy #csuite #EPRTalks